Casdin Capital, LLC Pliant Therapeutics, Inc. Transaction History
Casdin Capital, LLC
- $1.16 Billion
- Q2 2024
A detailed history of Casdin Capital, LLC transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Casdin Capital, LLC holds 1,000,000 shares of PLRX stock, worth $15.2 Million. This represents 0.93% of its overall portfolio holdings.
Number of Shares
1,000,000
Previous 1,000,000
-0.0%
Holding current value
$15.2 Million
Previous $10.8 Million
-0.0%
% of portfolio
0.93%
Previous 0.93%
Shares
5 transactions
Others Institutions Holding PLRX
# of Institutions
160Shares Held
63.8MCall Options Held
481KPut Options Held
105K-
Deep Track Capital, LP Greenwich, CT5.97MShares$90.8 Million2.11% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$75.6 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.6MShares$70 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.44MShares$52.2 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN3.4MShares$51.7 Million3.33% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $740M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...